AbbVie has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady and ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Abbott Laboratories (ABT – Research Report) on November 15 and set a price ...

AbbVie (ABBV) took a big hit after an adult schizophrenia drug missed its primary endpoint in mid-stage trials. Analysts are ...

CNBC’s Jim Cramer on Friday evaluated the stock of Abbott Laboratories, a healthcare company that’s been weighed down by ...

A court in St. Louis, Missouri ruled in favor of Abbott Laboratories and Reckitt Benckiser over claims their specialized baby ...

'Mad Money' host Jim Cramer takes a closer look at the litigation facing Abbott Labs. Kamala Harris Scores Major Endorsement ...

On Tuesday, Abbott Laboratories (ABT) stock saw a modest uptick, ending the day at $117.73 which represents a slight increase of $0.08 or 0.07% from the prior close of $117.65. The stock opened at ...

As Abbott Laboratories prepares to build a plant and bring 450 jobs to Bowling Green, company officials asked for permission to have more fencing and less greenery than required by city zoning. On ...

周一，巴克莱维持对Abbott Labs (NYSE:ABT)股票的增持评级，并将目标价从143美元上调至149美元。此次调整是在Abbott最近在圣路易斯的NEC诉讼中获得有利裁决后做出的。巴克莱分析师表示，尽管该股近期已有所上涨，包括从7月低点上涨18%，但距离他们对公司股票的新目标价仍有超过25%的上涨空间。

In July, Abbott Labs was forced to pay $495 million in damages after it lost to one plaintiff during the first complaint regarding the formula brought to trial. But Thursday night, the jury from ...

Abbott Laboratories and Reckitt Benckiser shares surged on Friday after a Missouri court ruled in the two companies’ favor in a dispute over claims their specialist infant formulas had caused a ...